Trial Profile

Phase II Study of Cetuximab Combined With IMRT and Concurrent Chemotherapy of Cisplatin in Nasopharyngeal Carcinoma.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cetuximab (Primary) ; Cisplatin
Indications Nasopharyngeal cancer
Focus Adverse reactions; Therapeutic Use
Acronyms ENCORE

Most Recent Events

02 Jun 2015 Five-year follow-up results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
31 Mar 2010 Additional lead trial centres identified as reported by ClinicalTrials.gov.
31 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com